Results 101 to 107 of about 2,443 (107)
Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort. [PDF]
Blood Cancer JBoudry A, Fenwarth L, Itzykson R, Braun T, Adès L, Fournier É, Berthon C, Lebon D, De Botton S, Peffault de Latour R, Pautas C, Dombret H, Raffoux E, Gardin C, Celli-Lebras K, Preudhomme C, Duployez N. +16 moreeuropepmc +1 more sourceChildhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.
BloodThalhammer J, Jeziorski E, Marec-Bérard P, Barkaoui MA, Pagnier A, Rohrlich PS, Chevallier A, Carausu L, Aladjidi N, Rigaud C, Leruste A, Azarnoush S, Lauvray T, Le Louet S, Gandemer V, Treguier P, Mansuy L, Pasquet M, Olivier L, Rome A, Saultier P, Isfan F, Renard C, Li Thiao Te V, Salmon A, Blanc L, Abou Chahla W, Lambilliotte A, Stephan JL, Geissmann F, Lejeune J, Mallebranche C, Reguerre Y, Grain A, Thomas C, Hélias-Rodzewicz Z, Moshous D, Fenneteau O, Coulomb-L'Hermine A, Lapillonne H, de Saint-Basile G, Emile JF, Héritier S, Donadieu J. +43 moreeuropepmc +1 more sourceFDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial. [PDF]
Blood AdvJamet B, Ahrari S, Zweegman S, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, Belhadj K, Itti E, Karlin L, Bailly C, Levin MD, Minnema MC, Bodet-Milin C, de Keizer B, Corre J, Sonneveld P, Mateus D, Moreau P, Touzeau C, Kraeber-Bodéré F, Carlier T. +22 moreeuropepmc +1 more sourceNovel RHCE*cE(341A) allele. [PDF]
TransfusionVoreux R, Vege S, Crépin O, Flahaut R, Ricard C, Ochoa-Garay G, Homich C, Sachais BS, Rahorst L, Velliquette RW, Barrault A, Tournamille C, Floch A. +12 moreeuropepmc +1 more source
